Cytosorbents (CTSO) Amortizatization of Intangibles (2010 - 2026)
Cytosorbents (CTSO) reported Amortizatization of Intangibles of $291000.0 for Q1 2026, up 708.33% on a YoY basis from $36000.0 in Q1 2025, and up 1019.23% quarter-over-quarter from $26000.0 in Q4 2025.
Cytosorbents (CTSO) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Cytosorbents has reported Amortizatization of Intangibles for 16 years, with the latest figure at $291000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 708.33% year-over-year to $291000.0; the trailing twelve-month figure through Mar 2026 stood at $390000.0 (up 52.9% YoY), and the FY2025 full-year result was $135000.0, down 49.06% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $291000.0, up from $26000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $398035.0 in Q4 2023, with the low at $26000.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $88492.0 across 5 years, with a median of $55440.0 in 2023.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles tumbled 86.07% — and 2026, when it soared 708.33%.
- Cytosorbents' Amortizatization of Intangibles stood at $55441.0 in 2022, then jumped by 617.94% to $398035.0 in 2023, then plunged by 68.09% to $127000.0 in 2024, then slumped by 79.53% to $26000.0 in 2025, then surged by 1019.23% to $291000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $291000.0 (Q1 2026), $26000.0 (Q4 2025), and $37000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Cytosorbents | 25.72 Mn | 20.92 Mn | 6.13 Mn | 291,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 291,000.00 |
| Mar 31, 2026 | 291,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 127,000.00 |
| Dec 31, 2024 | 127,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 46,073.00 |
| Jun 30, 2024 | 46,073.00 |
| Mar 31, 2024 | 45,927.00 |
| Mar 31, 2024 | 45,927.00 |
| Dec 31, 2023 | 398,035.00 |
| Dec 31, 2023 | 398,035.00 |